These mice were observed to develop marked hepatic steatosis in the absence of any abnormalities in plasma glucose and insulin levels, glucose and insulin tolerance, or infusion rates during hyperinsulinaemic euglycaemic clamp experiments. This evidence concerns the gene INS and fatty liver disease.